ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.0
  1. ホーム
  2. /反応

1,3-Propanediamine, N'-(ethylcarbonimidoyl)-N,N-dimethyl-, monohydrochloride → 3-[4-(2-Chloroethyl)phenyl]-5,7-dimethyl-2-[2-(1,3-thiazol-2-yl)ethyl]-3H-imidazo[4,5-b]pyridine

HRID 724035
ノート
印刷プレビュー

反応式

HRID 724035 の反応式
[Cl:1][CH2:2][CH2:3][C:4]1[CH:9]=[CH:8][C:7]([NH:10][C:11]2[C:16]([NH2:17])=[C:15]([CH3:18])[CH:14]=[C:13]([CH3:19])[N:12]=2)=[CH:6][CH:5]=1.[S:20]1[CH:24]=[CH:23][N:22]=[C:21]1[CH2:25][CH2:26][C:27](O)=O.Cl.C(N=C=NCCCN(C)C)C>ClCCl>[Cl:1][CH2:2][CH2:3][C:4]1[CH:9]=[CH:8][C:7]([N:10]2[C:11]3=[N:12][C:13]([CH3:19])=[CH:14][C:15]([CH3:18])=[C:16]3[N:17]=[C:27]2[CH2:26][CH2:25][C:21]2[S:20][CH:24]=[CH:23][N:22]=2)=[CH:6][CH:5]=1
参加物実験手順後処理出典と根拠反応ノート

参加物

5

反応物 3

HCID 27239391,3-Propanediamine, N'-(ethylcarbonimidoyl)-N,N-dimethyl-, monohydrochlorideHCID 27606093-(2-Thiazolyl)propionic acidHCID 69961874N2-[4-(2-Chloroethyl)phenyl]-4,6-dimethyl-2,3-pyridinediamine

生成物 1

HCID 218757313-[4-(2-Chloroethyl)phenyl]-5,7-dimethyl-2-[2-(1,3-thiazol-2-yl)ethyl]-3H-imidazo[4,5-b]pyridine収率 53%

試薬・触媒・溶媒 1

HCID 6344
Dichloromethane
溶媒

実験手順

To a mixture of N2-[4-(2-chloroethyl)phenyl]-4,6-dimethyl-2,3-pyridinediamine (step 2, 276 mg, 1.0 mmol) and 3-(1,3-thiazol-2-yl)propanoic acid (157 mg, 1.0 mmol) in dichloromethane (10 mL) was added 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide, hydrochloride (WSC) (192 mg, 1.0 mmol) in one portion. The reaction mixture was stirred overnight at room temperature. The reaction mixture was concentrated under reduced pressure. The residue was suspended in toluene (20 mL) and heated at 150° C. for 5 h. The reaction mixture was poured into water (50 mL), the organic phase was separated, and the aqueous phase was extracted with ethyl acetate (100 mL). The combined organic phases were washed with brine (50 mL) and dried (Na2SO4). After removal of solvent, the crude product was purified by flash column chromatography on silica gel eluting with hexane/ethyl acetate (1:1) to afford 210 mg (53%) of the title compound: MS (EI) m/z 396 (M+); 1H-NMR (CDCl3) δ 7.63 (1H, d, J=3.4 Hz), 7.39 (2H, d, J=8.3 Hz), 7.28 (2H, d, J=8.3 Hz), 7.15 (1H, d, J=3.4 Hz), 6.93 (1H, s), 3.78 (2H, t, J=7.4 Hz), 3.69–3.50 (2H, m), 3.39–3.20 (2H, m), 3.15 (2H, t, J=7.4 Hz), 2.66 (3H, s), 2.53 (3H, s).

後処理

  1. concentrationThe reaction mixture was concentrated under reduced pressure
  2. temperatureheated at 150° C. for 5 h
  3. additionThe reaction mixture was poured into water (50 mL)
  4. customthe organic phase was separated
  5. extractionthe aqueous phase was extracted with ethyl acetate (100 mL)
  6. washThe combined organic phases were washed with brine (50 mL)
  7. dry with materialdried (Na2SO4)
  8. customAfter removal of solvent
  9. customthe crude product was purified by flash column chromatography on silica gel eluting with hexane/ethyl acetate (1:1)

出典と根拠

ORDレコード
ord-35a5cd6f32044a64aa760d5327e68c17
出典データセット
uspto-grants-2006_11
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US07141580B2

反応ノート

読み込み中…

このページの内容参加物実験手順後処理出典と根拠反応ノート